105 related articles for article (PubMed ID: 19464901)
1. Identification of novel serotonin 2C receptor ligands by sequential virtual screening.
Ahmed A; Choo H; Cho YS; Park WK; Pae AN
Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling of the 3D structure of 5-HT(1A)R: discovery of novel 5-HT(1A)R agonists via dynamic pharmacophore-based virtual screening.
Xu L; Zhou S; Yu K; Gao B; Jiang H; Zhen X; Fu W
J Chem Inf Model; 2013 Dec; 53(12):3202-11. PubMed ID: 24245825
[TBL] [Abstract][Full Text] [Related]
3. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist.
Cho NC; Seo SH; Kim D; Shin JS; Ju J; Seong J; Seo SH; Lee I; Lee KT; Kim YK; No KT; Pae AN
J Comput Aided Mol Des; 2016 Aug; 30(8):625-37. PubMed ID: 27600555
[TBL] [Abstract][Full Text] [Related]
4. Ligand-directed serotonin 5-HT
Felsing DE; Canal CE; Booth RG
Eur J Pharmacol; 2019 Apr; 848():131-139. PubMed ID: 30689993
[TBL] [Abstract][Full Text] [Related]
5. Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists.
Galeazzi R; Massaccesi L; Piva F; Principato G; Laudadio E
J Mol Model; 2014 Mar; 20(3):2120. PubMed ID: 24562856
[TBL] [Abstract][Full Text] [Related]
6. Design of novel multiple-acting ligands towards SERT and 5-HT2C receptors.
Eliás O; Agai-Csongor E; Domány G; Keserű GM; Gere A; Kiss B; Hellinger E; Vastag M; Gyertyán I
Bioorg Med Chem Lett; 2014 May; 24(9):2118-22. PubMed ID: 24717153
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore Directed Screening of Agonistic Natural Molecules Showing Affinity to 5HT
Veeramachaneni GK; Thunuguntla VBSC; Bhaswant M; Mathai ML; Bondili JS
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31581577
[TBL] [Abstract][Full Text] [Related]
8. Fingerprint-based consensus virtual screening towards structurally new 5-HT(6)R ligands.
Smusz S; Kurczab R; Satała G; Bojarski AJ
Bioorg Med Chem Lett; 2015 May; 25(9):1827-30. PubMed ID: 25866241
[TBL] [Abstract][Full Text] [Related]
9. Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacology.
Lepailleur A; Freret T; Lemaître S; Boulouard M; Dauphin F; Hinschberger A; Dulin F; Lesnard A; Bureau R; Rault S
J Chem Inf Model; 2014 Jun; 54(6):1773-84. PubMed ID: 24857631
[TBL] [Abstract][Full Text] [Related]
10. New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands.
Kurczab R; Bojarski AJ
J Chem Inf Model; 2013 Dec; 53(12):3233-43. PubMed ID: 24245803
[TBL] [Abstract][Full Text] [Related]
11. Identification of fluorinated (R)-(-)-aporphine derivatives as potent and selective ligands at serotonin 5-HT
Xu Y; Sromek AW; Neumeyer JL
Bioorg Med Chem Lett; 2019 Jan; 29(2):230-233. PubMed ID: 30545651
[TBL] [Abstract][Full Text] [Related]
12. In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.
Lewellyn K; Bialonska D; Loria MJ; White SW; Sufka KJ; Zjawiony JK
Bioorg Med Chem; 2013 Nov; 21(22):7083-90. PubMed ID: 24084296
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT
Wild CT; Miszkiel JM; Wold EA; Soto CA; Ding C; Hartley RM; White MA; Anastasio NC; Cunningham KA; Zhou J
J Med Chem; 2019 Jan; 62(1):288-305. PubMed ID: 29620897
[TBL] [Abstract][Full Text] [Related]
14. Controversies on the role of 5-HT(2C) receptors in the mechanisms of action of antidepressant drugs.
Martin CB; Hamon M; Lanfumey L; Mongeau R
Neurosci Biobehav Rev; 2014 May; 42():208-23. PubMed ID: 24631644
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoinformatic and molecular docking studies reveal potential novel antidepressants against neurodegenerative disorders by targeting HSPB8.
Sehgal SA; Mannan S; Ali S
Drug Des Devel Ther; 2016; 10():1605-18. PubMed ID: 27226709
[TBL] [Abstract][Full Text] [Related]
16. We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.
Cheng J; Kozikowski AP
ChemMedChem; 2015 Dec; 10(12):1963-7. PubMed ID: 26507582
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT
Wold EA; Garcia EJ; Wild CT; Miszkiel JM; Soto CA; Chen J; Pazdrak K; Fox RG; Anastasio NC; Cunningham KA; Zhou J
J Med Chem; 2020 Jul; 63(14):7529-7544. PubMed ID: 32567857
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel antagonists of human neurotensin receptor 1 on the basis of ligand and protein structure.
Zhang G; Wang K; Li XD; Zhang DL; Xu F
Biomed Pharmacother; 2016 Dec; 84():147-157. PubMed ID: 27643557
[TBL] [Abstract][Full Text] [Related]
19. Cell-based and virtual fragment screening for adrenergic α2C receptor agonists.
Szőllősi E; Bobok A; Kiss L; Vass M; Kurkó D; Kolok S; Visegrády A; Keserű GM
Bioorg Med Chem; 2015 Jul; 23(14):3991-9. PubMed ID: 25648685
[TBL] [Abstract][Full Text] [Related]
20. Ligand-based pharmacophore modelling and screening of DNA minor groove binders targeting Staphylococcus aureus.
Vijayalakshmi P; Selvaraj C; Shafreen RM; Singh SK; Pandian SK; Daisy P
J Mol Recognit; 2014 Jul; 27(7):429-37. PubMed ID: 24895275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
